- Physician's Weekly

Innovative & Informative Prostate Cancer eBook

Nov 10, 2023

A curated ebook on prostrate cancer featuring recent studies, findings, and opinions from thought leaders.

Q&A: Assessing Patient Preferences Improves HIV Outcomes

Nov 10, 2023

Understanding the preferences of patients with HIV in care coordination programs, and revising programs based on those preferences, leads to better outcomes.

Telehealth in Otolaryngology Requires Balancing Accessibility & Quality

Nov 9, 2023

The expanded use of telemedicine in otolaryngology during the COVID-19 pandemic has shown how beneficial the approach can be for patients and clinicians.

Q&A: Sharing Knowledge Fosters a Better Understanding of MS

Nov 8, 2023

Progression independent of relapse activity explains why certain patients with MS continue to worsen clinically without MRI evidence of new lesions.

Q&A: Revisiting the Definition of Drug-Resistant Epilepsy

Nov 8, 2023

A joint report calls for reconsidering the definition of drug-resistant epilepsy, with a focus on epilepsy type and etiology

Come Down

Nov 8, 2023

“I think I’m coming down with something.”
“Then go back up again.”

Nearly a Third of Young Adult Men With ED Present With T2D

Nov 7, 2023

Young male patients presenting with erectile dysfunction should be screened for diabetes and prediabetes at presentation.

How Physicians Can Engage in Social Media Use Without Inviting a Malpractice Suit

Nov 7, 2023

Maintaining the utmost professionalism on social media apps is essential for physicians.

Bearing Witness to Life’s Milestones

Nov 6, 2023

As we move through our lives and progress through their various stages, we sometimes forget what got us to where we were going.

Does Lesion Location in Geographic Atrophy Impact Quality of Life?

Nov 6, 2023

A recent study tries to paint a clearer picture of the correlation between structural and functional markers of geographic atrophy.

Lifestyle Intervention Linked With Higher pCR in Women on Neoadjuvant Chemo

Nov 3, 2023

Patients in the intervention group significantly improved their diet quality and physical activity levels from baseline, compared with those in usual care.

FOLFIRINOX Equals Gemcitabine-Based Chemoradiotherapy for Pancreatic Cancer

Nov 2, 2023

Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy were comparably effective for pancreatic cancer.

Erdafitinib Similar to Pembrolizumab for Urothelial Cancer

Nov 2, 2023

Erdafitinib did not outperform pembrolizumab as second-line treatment for metastatic urothelial carcinoma.

Short Induction Chemo Improves Survival in Advanced Cervical Cancer

Nov 2, 2023

Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.

First Effective First-Line Chemo/Immunotherapy Combo for Urothelial Cancer

Nov 2, 2023

Nivolumab plus chemotherapy is the first combination to outperform chemotherapy alone as first-line treatment for unresectable or metastatic urothelial cancer.

Superior PFS With Sotorasib in Colorectal Cancer

Nov 2, 2023

Patients with KRAS (G12C)-mutated, metastatic colorectal cancer (CRC) benefit from combination sotorasib and panitumumab

“LAG Time” Promising First-Line Treatment for Metastatic NSCLC

Nov 2, 2023

Soluble LAG-3 protein eftilagimod alpha combined with pembrolizumab shows promising clinical efficacy as first-line treatment for advanced or metastatic NSCLC.